Jeremic B, Shibamoto Y, Stanisavljevic B, Milojevic L, Milicic B, Nikolic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 1997;43:29–37. https://doi.org/10.1016/s0167-8140(97)00048-0.

Article  PubMed  CAS  Google Scholar 

Kato K, Cho BC, Takahashi M, Okada M, Lin C-Y, Chin K, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20:1506–17. https://doi.org/10.1016/S1470-2045(19)30646-1.

Article  PubMed  CAS  Google Scholar 

Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18:651–8. https://doi.org/10.1200/JCO.2000.18.3.651.

Article  PubMed  CAS  Google Scholar 

Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. a meta-analysis. Oral Oncol. 2014;50:163–7. https://doi.org/10.1016/j.oraloncology.2013.12.002.

Article  PubMed  CAS  Google Scholar 

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32:3048–58. https://doi.org/10.1200/JCO.2013.53.5229.

Article  PubMed  PubMed Central  Google Scholar 

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68. https://doi.org/10.1200/JCO.2013.54.8800.

Article  PubMed  PubMed Central  Google Scholar 

Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, et al. US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: southwest oncology group S0816. J Clin Oncol. 2016;34:2020–7. https://doi.org/10.1200/JCO.2015.63.1119.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Johnson P, Federico M, Kirkwood A, Fosså A, Berkahn L, Carella A, et al. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma. N Engl J Med. 2016;374:2419–29. https://doi.org/10.1056/NEJMoa1510093.

Article  PubMed  PubMed Central  Google Scholar 

Mahajan A, Ahuja A, Sable N, Stambuk HE. Corrigendum to Imaging in oral cancers: a comprehensive review [Oral Oncol. 104 (2020) 104658]. Oral Oncol. 2020;111:104956. https://doi.org/10.1016/j.oraloncology.2020.104956.

Article  PubMed  Google Scholar 

Creff G, Devillers A, Depeursinge A, Palard-Novello X, Acosta O, Jegoux F, et al. Evaluation of the prognostic value of FDG PET/CT parameters for patients with surgically treated head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2020;146:471–9. https://doi.org/10.1001/jamaoto.2020.0014.

Article  PubMed  Google Scholar 

Kim M, Gu W, Nakajima T, Higuchi T, Ogawa M, Shimizu T, et al. Texture analysis of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab. Ann Nucl Med. 2021;35:871–80. https://doi.org/10.1007/s12149-021-01623-6.

Article  PubMed  CAS  Google Scholar 

Fukushima Y, Suzuki K, Kim M, Gu W, Yokoo S, Tsushima Y. Evaluation of bone marrow invasion on the machine learning of 18 F-FDG PET texture analysis in lower gingival squamous cell carcinoma. Nucl Med Commun. 2024;45:406–11. https://doi.org/10.1097/MNM.0000000000001826.

Article  PubMed  CAS  Google Scholar 

Kim M, Higuchi T, Nakajima T, Andriana P, Hirasawa H, Tokue A, et al. 18F-FDG and 18F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma. Oral Radiol. 2019;35:308–14. https://doi.org/10.1007/s11282-019-00377-2.

Article  PubMed  PubMed Central  Google Scholar 

Cheson BD. Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol. 2015;4:5. https://doi.org/10.3978/j.issn.2304-3865.2014.11.03.

Article  PubMed  Google Scholar 

Beichel RR, Ulrich EJ, Smith BJ, Bauer C, Brown B, Casavant T, et al. FDG PET based prediction of response in head and neck cancer treatment: assessment of new quantitative imaging features. PLoS ONE. 2019;14:e0215465. https://doi.org/10.1371/journal.pone.0215465.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin Y-C, Chen S-W, Hsieh T-C, Yen K-Y, Yang S-N, Wang Y-C, et al. Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy. J Nucl Med. 2015;56:183–9. https://doi.org/10.2967/jnumed.114.148023.

Article  PubMed  CAS  Google Scholar 

Schöder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50(Suppl 1):74S-88S. https://doi.org/10.2967/jnumed.108.057208.

Article  PubMed  CAS  Google Scholar 

Miceli A, Jonghi-Lavarini L, Santo G, Cassarino G, Linguanti F, Gazzilli M, et al. [18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond. Clin Transl Imaging. 2023;11:421–37. https://doi.org/10.1007/s40336-023-00578-0.

Article  Google Scholar 

Zhong J, Sundersingh M, Dyker K, Currie S, Vaidyanathan S, Prestwich R, et al. Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort. Sci Rep. 2020;10:4086. https://doi.org/10.1038/s41598-020-60739-3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P. The Warburg effect: insights from the past decade. Pharmacol Ther. 2013;137:318–30. https://doi.org/10.1016/j.pharmthera.2012.11.003.

Article  PubMed  CAS  Google Scholar 

Bensinger SJ, Christofk HR. New aspects of the Warburg effect in cancer cell biology. Semin Cell Dev Biol. 2012;23:352–61. https://doi.org/10.1016/j.semcdb.2012.02.003.

Article  PubMed  CAS  Google Scholar